Thanks Mozz IMO you shouldn't even bother justifying yourself or responding to "rose colour" comments given you've always come across balances and pragmatic.
My 5c worth. It's been exceptional grating on many of us to see PR continue to award himself an exceptional generous package. He alone has drained shareholder equity >$20M (not including his 20M share holding). Amos confirmed they hadn't benchmarked REM until more recently and then arrived at $1M base. The effort they then went to via amending AGM resolutions in order to further feed from the trough was insulting given he also knew in advance of the CR and likely cashflow projections into year end.
He hasn't endeared himself to what the market now requires from a top notch CEO/Chair. You get awarded the big $$$ but ONLY after your look after shareholders and your customers first. Refer to MQG for example.
As a result we now have a CEO/Chair on probably the highest CEO-Chair package/EV on the ASX, despite some serious concerns on our ability to fund P3. In fact even with the 20% discount I can't see any list ASX CEO anywhere near the same multiple.
- Forums
- ASX - By Stock
- PAR
- Ann: PAR Appoints Business Development Consultant
Ann: PAR Appoints Business Development Consultant, page-243
Featured News
Add PAR (ASX) to my watchlist
(20min delay)
|
|||||
Last
24.0¢ |
Change
0.015(6.67%) |
Mkt cap ! $83.98M |
Open | High | Low | Value | Volume |
22.5¢ | 24.0¢ | 22.5¢ | $173.6K | 743.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 99346 | 22.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
24.0¢ | 131244 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 99346 | 0.225 |
5 | 44676 | 0.220 |
7 | 82313 | 0.215 |
13 | 181424 | 0.210 |
8 | 128042 | 0.205 |
Price($) | Vol. | No. |
---|---|---|
0.240 | 131244 | 5 |
0.245 | 56918 | 2 |
0.250 | 89857 | 4 |
0.255 | 100000 | 1 |
0.260 | 1333 | 1 |
Last trade - 16.10pm 13/11/2024 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online